tracking the news, one byte at a time
Freak Pulse
Category: Alzheimer’s Disease and Frontal Temporal Dementia
-
Dementia September 7, 2026: New Alzheimer’s genetic score improves risk prediction across ancestry groups
Researchers developed a multiancestry Alzheimer’s polygenic risk score using genetic data from European, African American, Caribbean Hispanic, and East Asian populations, then tested it across several independent and…
-
Dementia August 31, 2026: Scientist’s brainstorm transforms dementia-risk testing (Portnews.Au)
Neurologist Jane Alty, recruited by the University of Tasmania in 2019, observed that dementia patients in a clinic waiting room showed Parkinson’s-like movement changes, leading to a controversial theory that dementia…
-
Dementia August 24, 2026: Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease
A study published online Aug. 12 in Neurology examined the association between estrogen-only menopausal hormone therapy (MHT) use and Alzheimer disease (AD)-related outcomes in women aged 50 years or older from the…
-
Dementia August 24, 2026: FDA clears innovative blood test for earlier Alzheimer’s diagnosis
FDA clears blood tests for early Alzheimer’s detection this week: The FDA has cleared for marketing PrecivityAD2, a blood test developed by C2N Diagnostics using technology invented; and The FDA has cleared for marketing PrecivityAD2, a…
-
Dementia August 17, 2026: Newer blood thinners linked
A Swedish registry study of 7,308 patients with both Alzheimer’s disease and atrial fibrillation found that those taking newer blood thinners (NOACs) showed slower cognitive decline on the MMSE than those on warfarin…
-
Dementia August 10, 2026: Phase 1 Trial Validates Anti-PD-L1, 13 More Dementia-Free Years ARIC
Alzheimer’s Disease and Frontal Temporal Dementia this week: ImmunoBrain’s IBC-Ab002, a humanized anti-PD-L1 antibody designed to rejuvenate peripheral immune function rather; and A 26-year ARIC cohort analysis of 12,409 Americans found…
-
Dementia August 3, 2026: Alzheimer’s Still Have No Approved, Alzheimer’s blood tests are transforming, Lifestyle Changes May Slow Brain
Alzheimer’s Disease and Frontal Temporal Dementia this week: Bristol Myers Squibb has pushed topline readouts for its three ADEPT trials of Cobenfy in Alzheimer’s disease; and At the Alzheimer’s Association International Conference in…
-
Dementia July 27, 2026: Alzheimer’s Blood Test Now Works, Lab-grown mini brains may predict, single brain factor it shields, and more
Alzheimer’s Disease and Frontal Temporal Dementia this week: A real-world study presented at AAIC 2026 in London found that the PrecivityAD2 blood test, measuring p-tau217 and; and Johns Hopkins researchers grew hindbrain organoids from…
-
Dementia July 20, 2026: What Biogen’s anti-tau Alzheimer’s drug, AAIC 2026 Bold approaches, Cell-type signatures of, and more
Alzheimer’s Disease and Frontal Temporal Dementia this week: Biogen’s Phase 2 trial of an anti-tau therapy, BIIB080, showed a 26% reduction in cognitive decline at the lowest; and At AAIC 2026 in London, researchers presented advances in…
-
Decreasing Productivity Can Precede a Dementia Diagnosis by Years
Alzheimer’s Disease and Frontal Temporal Dementia this week: A study published in *Neurology* tracked 793 early-onset dementia patients against matched controls using Finnish; and This matters for Alzheimer’s Disease and Frontal Temporal…